Literature DB >> 28000523

CXCR2 inhibition in pancreatic cancer: opportunities for immunotherapy?

Jennifer P Morton1,2, Owen J Sansom1,2.   

Abstract

Entities:  

Keywords:  CXCR2; anti-PD1; chemokines; immunotherapy; metastasis; pancreatic cancer

Mesh:

Substances:

Year:  2017        PMID: 28000523     DOI: 10.2217/imt-2016-0115

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


× No keyword cloud information.
  7 in total

Review 1.  Combination Therapies Targeting HDAC and IKK in Solid Tumors.

Authors:  Ivana Vancurova; Mohammad M Uddin; Yue Zou; Ales Vancura
Journal:  Trends Pharmacol Sci       Date:  2017-12-09       Impact factor: 14.819

2.  The prognostic value of CXC chemokine receptor 2 (CXCR2) in cancers: a meta-analysis.

Authors:  Bingbing Qiao; Wenqin Luo; Yanna Liu; Jing Wang; Chuan Liu; Zhao Liu; Sizhe Chen; Jingjing Gu; Xiaolong Qi; Tongwei Wu
Journal:  Oncotarget       Date:  2017-12-11

3.  ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling.

Authors:  Andreia V Pinho; Mathias Van Bulck; Lorraine Chantrill; Mehreen Arshi; Tatyana Sklyarova; David Herrmann; Claire Vennin; David Gallego-Ortega; Amanda Mawson; Marc Giry-Laterriere; Astrid Magenau; Gunther Leuckx; Luc Baeyens; Anthony J Gill; Phoebe Phillips; Paul Timpson; Andrew V Biankin; Jianmin Wu; Ilse Rooman
Journal:  Nat Commun       Date:  2018-11-30       Impact factor: 14.919

4.  Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients.

Authors:  Seon Ah Lim; Jungwon Kim; Seunghyun Jeon; Min Hwa Shin; Joonha Kwon; Tae-Jin Kim; Kyungtaek Im; Youngmin Han; Wooil Kwon; Sun-Whe Kim; Cassian Yee; Seong-Jin Kim; Jin-Young Jang; Kyung-Mi Lee
Journal:  Front Immunol       Date:  2019-04-09       Impact factor: 7.561

Review 5.  Chemokines Modulate Immune Surveillance in Tumorigenesis, Metastasis, and Response to Immunotherapy.

Authors:  Anna E Vilgelm; Ann Richmond
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

Review 6.  Up-to-Date Tailored Systemic Treatment in Pancreatic Ductal Adenocarcinoma.

Authors:  Caroline Y K Fong; Emma Burke; David Cunningham; Naureen Starling
Journal:  Gastroenterol Res Pract       Date:  2019-09-05       Impact factor: 2.260

7.  Promoter Hypermethylation of CHODL Contributes to Carcinogenesis and Indicates Poor Survival in Patients with Early-stage Colorectal Cancer.

Authors:  Xinyue Zhang; Kaiming Wu; Yuhua Huang; Lixia Xu; Xiaoxing Li; Ning Zhang
Journal:  J Cancer       Date:  2020-02-28       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.